GSK
899 hedge funds and large institutions have $15.6B invested in GSK in 2022 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 348 increasing their positions, 268 reducing their positions, and 127 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 17 → 17 (0)
3% less funds holding
Funds holding: 928 → 899 (-29)
19% less first-time investments, than exits
New positions opened: 103 | Existing positions closed: 127
Holders
899
Holding in Top 10
17
Calls
$459M
Puts
$251M
Top Buyers
| 1 | +$1.53B | |
| 2 | +$319M | |
| 3 | +$156M | |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$94.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$80.1M |
Top Sellers
| 1 | -$501M | |
| 2 | -$401M | |
| 3 | -$162M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$78.3M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$57.1M |